Searched for
SOFTGEL
JM Financial initiates coverage on OneSource Specialty Pharma with a Buy call, target price Rs 2,049JM Financial initiates a Buy call on OneSource Specialty Pharma, setting a target price of Rs 2,049, driven by its unique CDMO positioning ...- Linking spurious drugs with legitimate manufacturers has severe reputational, financial impact: IPAThe Indian Pharmaceutical Alliance (IPA) has called for a clear distinction between spurious and sub-standard drugs following a CDSCO repor...
- Fundamental Radar: Three factors seen driving 20% PAT CAGR for Marksans PharmaMarksans Pharma derives a significant portion of its sales from OTC products in the US and UK markets. It has a strong presence in these ma...
- Fundamental Radar: Why is Caplin Point Labs poised to see a 20% upside?For Caplin Point, both the US and emerging markets of Latin America and Africa continued to grow, and with a healthy order book and drug ap...
- Stocks in news: Tata Steel, Delta Corp, Strides Pharma, Century Textiles, Welspun CorpAshish Kacholia has sold stake in Delta Corp Ltd through bulk deals on Monday. The ace investor has offloaded about 15 lakh shares 0.56% in...
- Strides Pharma announces business rejig. Shares end 7% up, hit 52 week highThe announcement was made by the company ahead of the market closing. The stock settled at Rs 536 on the NSE, up Rs 37, or 7% over Friday's...
- Marksans stock zooms 12% after news of Tevapharm facility buyDespite the rally, its shares have dropped 10 per cent in the last one month and the stock has tumbled 25 per cent so far in 2022
- Stocks in the news: RIL, Wipro, JSW Steel, Tata Power and Max HealthcareThe government hiked the windfall profit tax on the export of diesel to Rs 7 per litre and brought back a tax on jet fuel exports, but slas...
- Strides Pharma arm gets USFDA nod to market Amantadine Hydrochloride Softgel Capsules in AmericaStrides Pharma Global Pte Ltd Singapore has received approval from the US Food and Drug Administration (USFDA) for the medication, the comp...
- Strides gets USFDA nod for anti-allergic drugThe company said, it is focusing on building a private label business in the US by leveraging its portfolio of products across softgels, ta...
- Strides Pharma gets tentative nod from USFDA for pain relieving drugStrides Pharma Global Pte Ltd, Singapore, has received tentative approval for Diclofenac Potassium Softgel Capsules, 25 mg from the United ...
- Buy Dishman Carbogen Amcis, target Rs 380: HDFC SecuritiesBuy Dishman Carbogen Amcis at a price target of Rs 380.
- Hold Marksans Pharma, target Rs 31: Centrum BrokingHold Marksans Pharma Ltd. at a price target of Rs 31.0 .
- Strides Arcolab gets USFDA nod for Benzonatate capsulesThe product will be manufactured at the company's oral dosage facility at Bengaluru and marketed by the company in the US, it added.
- Strides Arcolab gets US drug regulator nod for Calcitriol softgel capsulesThe product will be manufactured at the company's oral dosage facility at Bengaluru and marketed in the US market, Strides Arcolab said.
- Zandu founders Parekhs to invest Rs 150 cr in Gujarat nutraceuticals plantThe Parekhs own Gujarat Research Allopathic Foundation (GRAF) Laboratories Ltd, an allopathy unit of Zandu set up in 2000 that was not sold...
- Amway India to invest Rs 400 cr to build Tamil Nadu manufacturing unitAmway India Enterprises on Wednesday said it plans to invest Rs 400 crore in the first phase of new manufacturing facility at Nilakottai in...
- Strides Arcolab may fetch Rs 1250 cr from sale of domestic unitsStrides has received offers from a variety of global generic drug manufacturers as well as some Indian drug-makers and PE funds for the bus...
- Money inflow intact, 4 pharma FDI plans okayedThe Foreign Investment Promotion Board (FIPB) examines FDI proposals that are on the approval route, but in the case of pharmaceutical sect...
- Ranbaxy partners with Validus to sell calcium drug in USRanbaxy Laboratories on Thursday said it has entered into an agreement with the US-based Validus Pharma for selling low cost versions of it...
Load More
